Loma Lux Psoriasis
- Manufacturer
- Apotheca Company
- Effective date
- 2011-07-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:14
Label at a glance#
ProductLoma Lux Psoriasis
Active ingredientPOTASSIUM BROMIDE, SODIUM BROMIDE, NICKEL SULFATE HEXAHYDRATE, POTASSIUM SULFATE, ZINC BROMIDE
Label structure9 sections
Contacts and useful links#
Websitewww.lomalux.com
www.lomalux.com
www.lomalux.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: HPUS Homeopathic Liquid - Kali bromatum 1X, Natrum bromatum 2X, Niccolum sulphuricum 3X, Zincum bromatum 4X, Kali sulphuricum 4X.
OTC - PURPOSE SECTION
For relief from the scaling, itching and redness of Psoriasis and Seborrhea.
WARNINGS SECTION
WARNINGS: Do not use if pregnant or nursing.
If allergic to nickel or costume jewelry, use only under the advice and supervision of a physician.
If symptoms worsen, contact a physician.
Keep out of reach of children.
CAUTION: Use only as directed.
Do not give to children under ten years old or use in the presence of kidney disease.
If skin rash appears or if nervous symptoms persist, recur frequently or are unusual, discontinue use and consult a physician.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Take medication orally at the beginning of the day before eating or drinking anything other than water. Take nothing but water for one hour after taking medication in order to improve absorption. Continue Loma Lux Psoriasis as long as it is beneficial to your overall condition. Recommended minimum duration for treatment is 4-5 months.
Weight Daily Dosage Bottle Lasts
50-100 lbs 1/2 tsp 96 days
100-150 lbs 1 tsp 48 days
150-200 lbs 1 1/2 tsp 36 days
Over 200 lbs 2 tsp 24 days
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Purified water, USP alcohol 2%, methyl paraben 0.15%, propyl paraben 0.03%.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF THE REACH OF CHILDREN.
INDICATIONS & USAGE SECTION
For relief from the scaling, itching and redness of Psoriasis and Seborrhea.
OTC - QUESTIONS SECTION
Manufactured and dist. by:
LOMA LUX LABORATORIES
P.O. BOX 702418
TULSA, OK 74170-2418
Questions? Call us!
800-316-9636
More information? Visit our web site:
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
LOMA LUX
LOMA LUX PSORIASIS
For relief from the scaling, itching and redness of Psoriasis and Seborrhea
TAKE ORALLY
HOMEOPATHIC MEDICINE
8 FL. OZ (237 ml)
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0712-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fa09-f424-e053-dadaa90a57ce | Loma Lux Psoriasis |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0712-1 | Loma Lux Psoriasis | 237 mL in 1 BOTTLE | LIQUID | 237 | 1 | |
| 57520-0712-2 | Loma Lux Psoriasis | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 57520-0712-3 | Loma Lux Psoriasis | 1 in 1 CARTON | LIQUID | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0712 | LOMA LUX PSORIASIS (KALI BROMATUM, NATRUM SULPHURICUM, NICCOLUM SULPHURICUM, KALI SULPHURICUM, ZINCUM BROMATUM,) LIQUID [APOTHECA COMPANY] | 1 | Legacy NDC, 3 package rows | 20110706_06616a68-5a01-4a8f-9269-6c28825cf0a7.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| NICKEL SULFATE HEXAHYDRATE | ACTIVE INGREDIENT | JC9WZ4FK68 | 1 | |
| POTASSIUM BROMIDE | ACTIVE INGREDIENT | OSD78555ZM | 1 | |
| POTASSIUM SULFATE | ACTIVE INGREDIENT | 1K573LC5TV | 1 | |
| SODIUM BROMIDE | ACTIVE INGREDIENT | LC1V549NOM | 1 | |
| ZINC BROMIDE | ACTIVE INGREDIENT | OO7ZBU9703 | 1 | |
| NICKEL | ACTIVE MOIETY | 7OV03QG267 | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Loma Lux Psoriasis
- Kali bromatum, Natrum sulphuricum, Niccolum Sulphuricum, Kali sulphuricum, Zincum bromatum,
- POTASSIUM BROMIDE
- POTASSIUM CATION
- SODIUM BROMIDE
- SODIUM CATION
- NICKEL SULFATE HEXAHYDRATE
- NICKEL
- POTASSIUM SULFATE
- ZINC BROMIDE
- ZINC CATION
- ALCOHOL
- WATER
- METHYLPARABEN
- PROPYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0712 | 57520-0712-1, 57520-0712-2, 57520-0712-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POTASSIUM BROMIDE | OSD78555ZM | ACTIB |
| SODIUM BROMIDE | LC1V549NOM | ACTIB |
| NICKEL SULFATE HEXAHYDRATE | JC9WZ4FK68 | ACTIB |
| POTASSIUM SULFATE | 1K573LC5TV | ACTIB |
| ZINC BROMIDE | OO7ZBU9703 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / OPHTHALMIC | 0.01 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / VAGINAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IONTOPHORESIS | 0.1 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAVENOUS | 5 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / RECTAL | 271 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUPPOSITORY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SYRUP / ORAL | 40 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CONCENTRATE / ORAL | 12 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / ORAL | 1 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | 3 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4cefb645-9980-44f7-8e11-794448d38366 | 06616a68-5a01-4a8f-9269-6c28825cf0a7 | 2011-07-05 | Warnings | 4cefb645-9980-44f7-8e11-794448d38366 06616a68-5a01-4a8f-9269-6c28825cf0a7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.